Budesonide News
TOPIGEN Pharmaceuticals Announces Management Changes - Earthtimes
A multi-center Phase 2 study to compare the safety and efficacy of TPI 1020 versus budesonide (a marketed inhaled steroid) is currently recruiting patients ...
TOPIGEN Pharmaceuticals Announces Management Changes - Earthtimes
A multi-center Phase 2 study to compare the safety and efficacy of TPI 1020 versus budesonide (a marketed inhaled steroid) is currently recruiting patients ...
HEALTH: Daily asthma meds keep lungs in play during exercise - Daily Times
all 6 news articles
Meda AB (publ) - 2007 Year-End Report - Centre Daily Times
Novopulmon (budesonide Novolizer, asthma treatment) rose 10% to SEK 172.5 million (157.3). The launch of budesonide 400 ug in several European markets ...
Street Tips: Progressive Following on MAP Pharmaceuticals Inc - Trading Markets (press release)
... including its two most advanced product candidates: UDB, a proprietary version of nebulized budesonide for the potential treatment of children with ...
MAP Pharmaceuticals Announces Resignation of Chief Medical Officer - FOXBusiness
"I am happy to have played a role in the development of our two lead product candidates, Unit Dose Budesonide (UDB) and MAP0004," stated Stephen B. ...
MAP Pharmaceuticals Announces Resignation of Chief Medical Officer - FOXBusiness
"I am happy to have played a role in the development of our two lead product candidates, Unit Dose Budesonide (UDB) and MAP0004," stated Stephen B. ...
AstraZeneca puts its faith in Crestor and biologics - Pharma Times (subscription)
... the Anglo-Swedish drugmaker’s big five – the cholesterol-lowerer Crestor (rosuvastatin), the asthma combination Symbicort (budesonide and formoterol), ...
MAP Pharmaceuticals to Present at the Merrill Lynch Global ... - CNNMoney.com
... including its two most advanced product candidates: UDB, a proprietary version of nebulized budesonide for the potential treatment of children with ...
Cipla sees milestone income of Rs 75cr - Moneycontrol.com
A: In European markets, we have received approvals for budesonide inhalers in Germany, Portugal, and Spain; for salbutamol in Denmark and Portugal; ...
Budesonide RSS Feed